US equities
|
MU
$969.01
▲+4.33%
META
$611.41
▼-1.42%
TSLA
$401.49
▼-1.47%
SPCX
$144.44
▼-2.79%
NVDA
$217.32
▼-0.28%
SNDK
$1,385.20
▲+6.16%
SKHY
$165.35
▲+13.75%
GOOGL
$324.86
▲+1.34%
MU
$969.01
▲+4.33%
META
$611.41
▼-1.42%
TSLA
$401.49
▼-1.47%
SPCX
$144.44
▼-2.79%
NVDA
$217.32
▼-0.28%
SNDK
$1,385.20
▲+6.16%
SKHY
$165.35
▲+13.75%
GOOGL
$324.86
▲+1.34%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
InMed Pharmaceuticals Inc. - Common Shares
(NQ:
INM
)
1.605
+0.015 (+0.94%)
Delayed Quote
Updated: 12:30 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about InMed Pharmaceuticals Inc. - Common Shares
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
20 Stocks Moving in Tuesday's Pre-Market Session
↗
May 03, 2022
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for...
Via
Benzinga
66 Biggest Movers From Yesterday
↗
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement
April 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement
April 28, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
18 Stocks Moving in Tuesday's Pre-Market Session
↗
April 26, 2022
Gainers Q&K International Group Limited (NASDAQ: QK) shares rose 59.2% to $1.56 in pre-market trading after dropping around 5% on Monday. Agile Therapeutics, Inc. (NASDAQ:...
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Announces Expansion Of Rare Cannabinoid Portfolio
↗
April 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio
April 21, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio
April 21, 2022
Via
CannabisNewsWire
Topics
Supply Chain
InMed Pharmaceuticals (NASDAQ: INM) Announces Participation In Upcoming Conferences
↗
April 20, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences
April 19, 2022
Via
Investor Brand Network
Topics
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences
April 19, 2022
Via
CannabisNewsWire
Topics
Cannabis
InMed Pharmaceuticals (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 19, 2022
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 18, 2022
Via
CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 18, 2022
Via
Investor Brand Network
InMed Pharmaceuticals Committed To Growing Market Reach, Product Portfolio
↗
March 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Committed to Growing Market Reach, Product Portfolio
March 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio
March 25, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
63 Biggest Movers From Yesterday
↗
March 25, 2022
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...
Via
Benzinga
InMed Pharmaceuticals Makes Changes In Management
↗
March 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Makes Changes in Management
March 18, 2022
Via
Investor Brand Network
InMed Launching Additional Rare Cannabinoids In Response To Demand
↗
March 17, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Demand
March 17, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
March 17, 2022
Via
CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
March 17, 2022
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
March 16, 2022
Via
CannabisNewsWire
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
March 16, 2022
Via
Investor Brand Network
Topics
Supply Chain
InMed Pharmaceuticals Inc. (NASDAQ: INM) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 10, 2022
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference
March 08, 2022
Via
Investor Brand Network
InMed Pharmaceuticals Expanding Portfolio In Rare Cannabinoid Market
↗
March 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Expanding Portfolio in Rare Cannabinoid Market
March 04, 2022
Via
Investor Brand Network
Topics
Supply Chain
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
